Northern Minerals confirms investor commitment to Browns Range
Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.
In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.
The below articles were written under our previous business model. We have kept these articles online here for your reference.
Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.
Click Here to View Latest Articles
Northern Minerals (ASX: NTU) has received confirmation from the parent company of two enterprises that had committed to a subscription agreement to Browns Range equating to a $30 million staged equity investment that the second and third tranches totalling $18 million will be met, albeit later than expected.
To date the subscribers (Huatai Mining and Taizhong Energy Australia) have made payments totalling $12 million to NTU and they were due to complete a further capital injection on November 28, 2016.
In a statement made by parent company, Shandong Taizhong Energy the group confirmed that its subsidiaries remained committed to the subscription agreement and the investment in NTU, and to this end will continue to use their best endeavours to complete the second and final tranche subscriptions as soon as funding is available.
Letter of guarantee being provided by Shandong Taizhong Energy
In consideration of a letter of guarantee being provided by Shandong Taizhong Energy, NTU has agreed to the requested extension which specifies that the total payment of $18 million is due for completion on or before December 28, 2016.
Confirmation that these arrangements will be completed by year-end provides certainty for NTU as it prepares to embark on the development of the Browns Range project, with a view to becoming the first significant world producer of dysprosium outside of China.
The increased certainty surrounding funding appears to have been well received by investors with the company’s shares up 4.3% in morning trading.
However it should be remembered that this is an early stage play and share trading patterns should not be used as the basis for an investment. Those considering this stock should seek independent financial advice.
General Information Only
S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.
Conflicts of Interest Notice
S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.
Publication Notice and Disclaimer
The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.
Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.
This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.
